Cell Wall Proteome Profiling of a <i>Candida albicans</i> Fluconazole-Resistant Strain from a Lebanese Hospital Patient Using Tandem Mass Spectrometry—A Pilot Study
<i>Candida albicans</i> is an opportunistic pathogenic fungus responsible for high mortality rates in immunocompromised individuals. Azole drugs such as fluconazole are the first line of therapy in fungal infection treatment. However, resistance to azole treatment is on the rise. Here, w...
Main Authors: | Andy Awad, Pamela El Khoury, Geovanni Geukgeuzian, Roy A. Khalaf |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/9/6/1161 |
Similar Items
-
Lactate Like Fluconazole Reduces Ergosterol Content in the Plasma Membrane and Synergistically Kills <i>Candida albicans</i>
by: Jakub Suchodolski, et al.
Published: (2021-05-01) -
Fluconazole impacts the extracellular matrix of fluconazole-susceptible and -resistant Candida albicans and Candida glabrata biofilms
by: Beatriz Helena Dias Panariello, et al.
Published: (2018-01-01) -
Synergistic Antifungal Activity of Chitosan with Fluconazole against Candida albicans, Candida tropicalis, and Fluconazole-Resistant Strains
by: Wei-Hsuan Lo, et al.
Published: (2020-11-01) -
Fructose Induces Fluconazole Resistance in <i>Candida albicans</i> through Activation of Mdr1 and Cdr1 Transporters
by: Jakub Suchodolski, et al.
Published: (2021-02-01) -
Fluconazole and Lipopeptide Surfactin Interplay During <i>Candida albicans</i> Plasma Membrane and Cell Wall Remodeling Increases Fungal Immune System Exposure
by: Jakub Suchodolski, et al.
Published: (2020-04-01)